进化揭示复苏疗法 在低血压冲击中使用仙酸的潜力
Ravinder Singh1, Varinder Singh1, Pratima Kumari1
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
CNS & neurological disorders drug targets
|June 26, 2023
概括
酸在治疗低血压休克方面显示出有前途,通过改善心脏输出量和组织 perfusion. 这种心血管药物耐受性很好,可能为低血压休克提供一种新的复苏疗法.
科学领域:
- 心血管药理学心血管药理学
- 临界护理医学 临界护理医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低血压性休克 (HS) 导致严重的死亡率,原因是组织 perfusion 不足.
- 目前的HS治疗方法,如液体复苏,具有局限性,包括全身炎症和器官衰竭.
- 酸 (CC),最初是一种抗高血压药,正在探索其在HS中的复苏潜力.
研究的目的:
- 审查中酸作为低血压休克的复苏剂的发展.
- 阐明HC中CC的作用机制和分子信号.
- 突出CC在HS治疗中未来临床应用的潜力.
主要方法:
- 对中酸的临床前和临床数据的审查.
- 在动物和人类研究中分析了CC的药理动力学概况.
- 研究CC与α2B-上腺素受体的相互作用.
主要成果:
- CC表现出积极的离子变效应,并通过α2B-上腺激动作用诱导静脉收缩.
- CC增加了心脏输出并增强了组织输液,表明了复苏能力.
- 药理动力学研究表明,CC在人类和动物中耐受性良好,副作用最小.
结论:
- 酸为低血压性休克复苏提供了一个有前途的治疗选择.
- CC的机制涉及增加静脉回归和心脏输出,改善 perfusion.
- 对CC分子信号的进一步研究是有必要的,以支持其在HS的临床使用.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
29
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
29
Continuous Renal Replacement Therapy
54
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
54
Blood Pressure Imbalances and Circulatory Shock
819
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
819
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Acute Respiratory Failure-V
169
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
169


